IRS 1 (phospho Ser639) Antibody
| Product name: | IRS 1 (phospho Ser639) Antibody |
| Source: | Rabbit |
| Purity: | >95% |
| Buffer Formulation: | Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Applications: | IHCWB |
| Storage: | Store antibody at -20˚C for up to one year. |
| UOM: | 100ug |
IRS 1 (phospho Ser639) Antibody
Catalog Number:IC282338
Product Profile
| Product Name | IRS 1 (phospho Ser639) Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Productdescription |
|
| Immunogen |
IRS-1 (Phospho-Ser639) antibody was raised against a peptide sequence around phosphorylation site of serine 639 (P-K-S (p) -V-S) derived from Human IRS-1. |
Key Feature
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | |
|
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100:
|
|
| Species Reactivity | |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
Target Information
| Gene Symbol | IRS1 |
|---|---|
| Alternative Names |
HIRS-1
More
NFKB3 IRS-1 IRS1 |
| Molecular Weight(MW) | 180 kDa |
| Tissue Specificity | This antibody detects endogenous level of IRS-1 only when phosphorylated at serine 639. |
Database Links
| Entrez Gene | 3667 |
|---|---|
| Protein Accession | NP_005535.1 |
Application
-
Application
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using IRS-1 (Phospho-Ser639).
-
Application
Western blot analysis of lysed extracts from 293 cells untreated or treated with serum using IRS-1 (Phospho-Ser639).
| Application Notes |
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100:
|
|---|
Additional Information
| Form | Liquid |
|---|---|
| StorageInstructions | Store antibody at -20˚C for up to one year. |
| Storage Buffer | Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.
|
|












